BH
GMAB icon

Burk Holdings’s Genmab GMAB Stock Holding History

Burk Holdings’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$440 Hold
16
– – ﹤0.01% 632
2026
Q1 		$429 Buy
+16
New +$479 ﹤0.01% 658

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Burk Holdings's GMAB Position: Q2 2026 in Review

Burk Holdings held its Genmab (GMAB) position steady in Q2 2026 at 16 shares worth $440. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Burk Holdings first reported a position in GMAB in Q1 2026 and has held it in 2 quarters since. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Burk Holdings held 16 shares of Genmab worth $440 as of Q2 2026.
  • Burk Holdings left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of Burk Holdings's portfolio in Q2 2026, its #632 holding.
  • Burk Holdings first reported a position in Genmab in Q1 2026 and has held it in 2 quarters since.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Burk Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.